Close Menu

NEW YORK (GenomeWeb) – Molecular diagnostics firm ChromaCode said today it has raised $12 million in a Series B funding round.

The round was led by New Enterprise Associates with participation from existing investors, Domain Associates and Okapi Ventures.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.